1-Tert-Butyl 4-Methyl 4-Allylpiperidine-1,4-Dicarboxylate
95%
- Product Code: 242770
CAS:
441774-09-0
Molecular Weight: | 283.36 g./mol | Molecular Formula: | C₁₅H₂₅NO₄ |
---|---|---|---|
EC Number: | MDL Number: | MFCD11977494 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature, sealed, dry |
Product Description:
Used as an intermediate in pharmaceutical synthesis, particularly in the development of active pharmaceutical ingredients (APIs) involving piperidine derivatives. Its functional groups allow for selective modifications, making it valuable in constructing complex nitrogen-containing molecules. Commonly employed in research settings for optimizing drug candidates targeting central nervous system disorders due to the piperidine scaffold’s prevalence in neuroactive compounds. The allyl group enables further chemical transformations, such as cross-coupling or cyclization reactions, facilitating the creation of diverse molecular architectures. Also utilized in medicinal chemistry for structure-activity relationship (SAR) studies to enhance potency and selectivity of new drug entities.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
0.250 | 10-20 days | $740.75 |
+
-
|
1.000 | 10-20 days | $1,480.65 |
+
-
|
1-Tert-Butyl 4-Methyl 4-Allylpiperidine-1,4-Dicarboxylate
Used as an intermediate in pharmaceutical synthesis, particularly in the development of active pharmaceutical ingredients (APIs) involving piperidine derivatives. Its functional groups allow for selective modifications, making it valuable in constructing complex nitrogen-containing molecules. Commonly employed in research settings for optimizing drug candidates targeting central nervous system disorders due to the piperidine scaffold’s prevalence in neuroactive compounds. The allyl group enables further chemical transformations, such as cross-coupling or cyclization reactions, facilitating the creation of diverse molecular architectures. Also utilized in medicinal chemistry for structure-activity relationship (SAR) studies to enhance potency and selectivity of new drug entities.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :